We could not find any results for:
Make sure your spelling is correct or try broadening your search.
| Ticker | Name | Price | Change | Change % | Volume | Trades |
|---|---|---|---|---|---|---|
HWKO | Hawk Resources Ltd | 0.002 | 0.001 | 100.00% | 565,000 | 3 |
1TTO | Thrive Tribe Technologies Ltd | 0.002 | 0.001 | 100.00% | 50,016 | 2 |
SLZO | Sultan Resources Ltd | 0.003 | 0.001 | 50.00% | 413,887 | 1 |
MFD | Mayfield Childcare Limited | 0.21 | 0.07 | 50.00% | 227,337 | 18 |
1TT | Thrive Tribe Technologies Ltd | 0.003 | 0.001 | 50.00% | 4,815,878 | 26 |
CCE | Carnegie Clean Energy Limited | 0.18 | 0.055 | 44.00% | 2,570,443 | 389 |
PNT | Panther Metals Ltd | 0.007 | 0.002 | 40.00% | 2,145,008 | 12 |
NEU | Neuren Pharmaceuticals Limited | 16.73 | 4.53 | 37.13% | 1,809,027 | 14,638 |
ATC | Altech Batteries Ltd | 0.008 | 0.002 | 33.33% | 26,481,196 | 170 |
DDT | Datadot Technology Limited | 0.004 | 0.001 | 33.33% | 4,898,652 | 10 |
COY | Coppermoly Limited | 0.004 | 0.001 | 33.33% | 143,429 | 2 |
LISHUI, China, June 29, 2026 /PRNewswire/ -- Farmmi, Inc. (NASDAQ: FAMI) (the "Company"), an agriculture products supplier in China and a logistics and supply chain services provider in the United States, today announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $3.0 million, before deducting underwriting fees and other offering expenses payable by the Company.
CHARLOTTE, N.C., June 29, 2026 /PRNewswire/ -- Honeywell Technologies (NASDAQ: HON) today announced it will issue its second quarter financial results before the opening of the Nasdaq Stock Market on Thursday, July 23. The results for the second quarter will include the former Aerospace Technologies segment, which is now operating as Honeywell Aerospace and trading on Nasdaq under the ticker symbol "HONA" following the spin-off from Honeywell today. Honeywell Technologies will hold a conference call at 8:30 a.m. EDT to discuss its second quarter performance and 2026 outlook.
Eleven sites open for patient enrollment in TakeAim CLL combination study with zanubrutinib; Company reaffirms guidance for dosing of initial five patients by end of July 2026 with data expected December 2026; Stockholders approve reverse stock split LEXINGTON, Mass., June 26, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced that eleven clinical sites have been initiated and are now open for patient enrollment in its Phase 2 TakeAim CLL study evaluating emavusertib in combination with zanubrutinib in patients with Chronic ...
Nixxy, Inc. (NASDAQ: NIXX) today announced that its proposed strategic combination with Tachyon 9 Corporation is advancing what the Company believes is a differentiated model for next-generation AI infrastructure: the $1 billion Nakota Data Campus, designed to deliver up to one gigawatt of AI computing capacity through a large-scale North Dakota development built around firm on-site power, a carbon-neutrality pathway and low-water cooling.
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Already have an account? Sign in
Don't have an account? Sign up
By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.